Funded Tech Companies
Excision BioTherapeutics
Excision BioTherapeutics is a leading biopharmaceutical growth company, based in San Francisco. Financial backing came from Norwest Venture Partners, IndusAge Partners and WRVI Capital.
Company Overview
Company Name
Excision BioTherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
988 Market St.
San Francisco, CA 94102
USA
San Francisco, CA 94102
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Excision BioTherapeutics Inc. is a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment and eradication of life-threatening disease caused by neurotropic viruses (viral infections).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/18/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Dornbusch
Chief Medical Officer
Revati Shreeniwas
Chief Scientific Officer
TJ Cradick
Chief Scientific Officer
Kamel Khalili
VP - Bus. Development
Michael Aberman
VP - R & D
Jenn Gordon
VP - Regulatory Affairs
Patricia Williams
Company Investors
- Norwest Venture Partners
- IndusAge Partners
- WRVI Capital
- ARTIS Ventures (Stuart Peterson)
- Olive Tree Capital
- Loreda Holding
- Anzu Partners
- Adjuvant Capital
- Cota Capital
- Greatpoint Ventures Innovation Fund (Ashok Krishnamurthi)
Browse more funded tech companies:
Excimus Biotech | Excision Medical
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs